Introduction {#Sec1}
============

Development of portable DNA sensors is of significant medical importance, as they find direct application in infectious disease diagnosis (Boon et al. [@CR4]; Kallioniemi et al. [@CR7]; Alwine et al. [@CR2]). For example, using DNA sensors, in case of viral infections, the genetic material of the virus (be in the RNA, or the c-DNA) inside an infected host can be detected using a complementary capture probe. Further, such devices can be utilized for mutation detection, where the target genetic material can be a mutant DNA, and the capturing probe can be complement of it. Notably, DNA sensors capable of mutation detection can find application in cancerous mutation detection. Towards the development of such sensors, several transduction principles have been used in the past, by researchers, globally (Sassolas et al. [@CR13]; Kim et al. [@CR8]; Yan et al. [@CR22]; Green and Norton [@CR6]; Wang and Li [@CR21]). Among them, electrochemical methods have been predominately explored, on account of their inherent advantages, in terms of sensitivity, limiting detection and amenability to miniaturization (Drummond et al. [@CR5]; Akhavan et al. [@CR1]; Ricci et al. [@CR12]; Bakker and Telting-Diaz [@CR3]). In general, solid state electrochemical DNA sensors use capture probe modified working electrodes, as the sensing interface, on to which the complementary target nucleotide is hybridized. The process of hybridization is then transduced in to a physically measurable entity, using one of the many sensitive electrochemical techniques such as electrochemical impedance spectroscopy, cyclic voltammetry, amperometry and differential pulse voltammetry. Further, electrochemical methods often facilitate label-free DNA detection, which does not involve any sandwiched assay, or additional signaling molecule other than the probe and target nucleotides. Such advantage is crucial, as it greatly simplifies the protocols and the chemistry associated with the development of the biosensors.

Keeping these in mind, in the past, we had adhered to label-free electrochemical sensing of DNA hybridization, for both wild type and mutant targets (Tripathy et al. [@CR17], [@CR18], [@CR19], [@CR20]). In addition, our group has developed a number of electrochemical immunoassays towards label-free detection of malarial parasite, atrazine and cardiac biomarkers (Paul et al. [@CR10]; Supraja et al. [@CR14], [@CR15], [@CR16]). During the course of development of such devices, the associated protocols were optimized for achieving superior sensitivity. In this paper, we propose to use this well-established electrochemical scheme as a potential approach for COVID-19 diagnosis. Given the current global situation, in relation to the ongoing pandemic, it is obviously essential that diagnosis methods are developed that are rapid, sensitive, target-specific, reproducible, technically robust, and cost effective. In particular, in case of the envisaged diagnosis platform, two important aspects are worth mentioning, when one considers using them in the field. The first point that needs attention is the portability of these sensors, which would allow them to be used as point-of-care diagnostic devices. Note, the problem of portability of these devices include the issue of device miniaturization, their interfacing with read-out systems, and subsequent data acquisition. Secondly, the economic aspects of a diagnostic device are of concern. Ideally, the cost associated with a diagnostic tool, which is to be used for mass-testing, has to be limited to affordable figures. Keeping both these aspects in mind, in this paper, an electrochemical DNA sensing approach has been discussed for the specific application.

We had earlier reported about electrochemical detection of Dengue virus specific single-stranded consensus primer, both from spiked buffer and spiked serum sample, using Mn~2~O~3~ nanofibers as transducing elements (Tripathy et al. [@CR17]).Therein, the sensing interface was prepared via dropcasting of the Mn~2~O~3~ nanofibers on to commercial available glassy carbon electrodes (GCEs), and subsequently, chemically anchoring the probe nucleotides onto the nanofibers. At a later stage, we had also developed another electrochemical platform using GCEs and graphene doped Mn~2~O~3~ nanofibers, for the detection of BRCA-1 gene specific wild type and mutant DNAs (Tripathy et al. [@CR18]). However, in both these cases, the DNA sensors were macroscopic. Their utilization in on-field diagnosis, understandably, needed miniaturization of the sensing platform and its integration with a portable readout system. To achieve this, we had proposed a novel fabrication protocol for developing a miniaturized electrochemical biosensor, and demonstrated the usability of the device towards DNA hybridization and point mutation detection, using PCR-amplified samples (Tripathy et al. [@CR20]). The concerned platform was envisaged to be a portable DNA-sensor, that can be used towards infectious disease diagnosis, such as Dengue and other viral or bacterial infections. In this paper, we intend to propose a plausible extension of the same platform towards COVID-19 diagnosis. The subsequent sections of this paper describe the detailed methodology and protocols associated with the same.

Methods and Protocols {#Sec2}
=====================

Device Development {#Sec3}
------------------

The proposed miniaturized device was developed on oxidized silicon substrates, using standard CMOS fabrication process flow and electrodeposition techniques. The working electrode for the sensor was realized with gold nanoparticles electrodeposited on to a Ti electrode, following previously established protocols (Tripathy et al. [@CR19]; Yi and Yu [@CR23]). The electrodeposition conditions were experimentally optimized, for desirable performance. The reference and counter electrodes were of Platinum. Here, for external interfacing of the biosensor, a male USB port was attached on to the platform, using an indigenous strategy. Further, a PDMS reservoir was anchored on to the device, which defined the reaction area, and effectively ensured confinement of the electrodes. A detailed description of the process flow has been provided elsewhere (Tripathy et al. [@CR20]). In Fig. [1](#Fig1){ref-type="fig"}, a schematic representation of the device is presented. Following the same protocol, a handheld electrochemical platform, with a well-defined reaction chamber, and a USB-based interfacing arrangement, can be developed, for COVID-19 specific DNA sensing. In addition, however, one may also opt for other fabrication techniques for developing the platform. Note, cost-effective methods such as screen printing of conductive metal inks on to low-cost platforms can be considered as alternatives.Fig. 1A schematic representation of the miniaturized electrochemical platform showing different components, with actual image of two fabricated devices

Protocols for Developing the Sensing Interface {#Sec4}
----------------------------------------------

The proposed electrochemical platform makes use of gold nanoparticles, electrodeposited on to a Ti surface, as the sensing electrode. This comes as a strategic improvement, in terms of stability and simplicity, over sensing interfaces that are prepared by physisorption of nanomaterials on to solid surfaces. Such surfaces, in general, are prone to inter-device variability, and are not wash proof. They stability of such interfaces against wet chemical steps is a matter of concern, as it may induce unwanted 'leaching' of material. On the contrary, the electrodeposited Au layer is highly stable, and immune to harsh chemical treatments, Au being a noble metal. This improvement in stability is desirable for on-field biomolecular detection, in relation to accuracy and reproducibility. To add to this, the Au nanostructure-based sensing interface is advantageous in terms of simplicity of biofunctionalization, as it facilitates the use of gold-thiol self-assembly method. Such a protocol is pretty well understood, and highly followed for DNA immobilization (Lucarelli et al. [@CR9]; Zhang et al. [@CR24]; Rasheed and Sandhyarani [@CR11]).

For the concerned case of COVID-19 diagnosis, this protocol can be utilized as shown in Fig. [2](#Fig2){ref-type="fig"}. Here, the target nucleotide can be the COVID-19 specific viral RNA, or the corresponding c-DNA, or any unique sequence specific to them. A complementary single-stranded probe can then be designed, with respect to the target sequence, with thiol modification at one end. The thiol modified probe can be attached on to the gold sensing electrodes via gold-thiol self-assembly, as described before. And subsequently, the sensing surface can be made diagnosis-ready, by blocking the non-specific binding sites, using any standard blocking agent. When the target nucleotide is introduced on to the sensor, through the designated reaction chamber, it hybridizes with the complementary probe, under favorable physiological conditions. This hybridization can be recorded using electrochemical techniques as described in the next sequence, and thereby, a diagnosis scheme is developed.Fig. 2A schematic representation of the probe DNA immobilization protocol on to the gold sensing electrodes, and the hybridization of the target nucleotide

Data Acquisition and Calibration {#Sec5}
--------------------------------

As discussed previously, the target hybridization on the sensor surface can be recorded via several electrochemical techniques, that converts this biophysical binding event in to a proportional electrical signal. A great deal of literature can be found in relation to these methods, and their advantages and shortcomings. Here, we are not discussing them in details. In this paper, we only intend to provide a means of data acquisition, that can be used in conjunction to the developed miniaturized platform, for COVID-19-specific diagnosis.

In our previous publications, we had used differential pulse voltammetry and electrochemical impedance spectroscopy, for recording the electrochemical response of DNA sensors (Tripathy et al. [@CR17], [@CR18],[@CR19], [@CR20]). Either of these methods can be used in the current situation, and in addition to them, one may also opt for the comparatively simpler method of amperometry. In either of the cases, an electrical signal (be it current, voltage or impedance) is recorded, that depicts the change in reaction kinetics at the sensing interface, directly correlating the same to the concentration of the COVID-19-specific target DNA. In general, when the target DNA binds to the surface immobilized capture probe, and the hybridization occurs, the overall surface charge on the biosensor changes significantly, in proportion to the concentration of the bound target, for a given probe density. This change in surface charge, in turn, alters the reaction kinetics, which is subsequently reflected in the system response. The sensor response can be recorded using an electrochemical workstation or any equivalent readout. In our case, the proposed miniaturized platform can be interfaced with such workstations or readouts, through the USB interface. As a matter of fact, the platform can also be interfaced with PCB based readouts or Arduino boards, and the data acquisition can be performed on a desktop or laptop. In our previous work, we had demonstrated one such instance with respect to the proposed platform, where amperometric data was recorded using an Arduino UNO board, and the PLX-DAQv2.xlsm worksheet which contains a macro (Tripathy et al. [@CR20]). The arrangement, however, can be extended to other methods, for the COVID-19 specific diagnosis.

Also, towards ensuring point-of-care diagnosis, it is imperative that portable read-out platforms are developed, that are simple and user-friendly. New and portable systems, in essence, can get rid of the bulky and table top electrochemical workstations, such that the sensors can be operated on field, without a laboratory facility. For a smarter healthcare, one can ideally aim at developing a readout that can be interfaced with smartphones and operated via software applications. In Fig. [3](#Fig3){ref-type="fig"}, a pictorial schematic is presented, showing the envisaged interfacing of the miniaturized device with a smartphone. Such systems will definitely increase the impact of diagnosis kits by manifolds, as with their availability, point-of-care biosensing can be performed on a larger scale, and the benefits of healthcare can reach a larger community.Fig. 3A schematic representation of the envisaged interfacing of the device with a smartphone

Conclusion {#Sec6}
==========

In this paper, label-free electrochemical detection of DNA hybridization has been presented as a potential approach for COVID-19 diagnosis. In relation to this, fabrication process flow of a miniaturized electrochemical biosensor is reported, and the related protocols for DNA sensing are laid out. As described, using complementary thiolated probes, COVID-19 specific viral RNA or c-DNA can be detected, and quantified, with the proposed platform. Note, development of such a full-fledged device may take 3--6 months, to be used in the concerned diagnosis. However, the DNA-hybridization based disease diagnosis requires the extraction of target DNA/RNA from the infected host and the subsequent sample preparation. Additionally, in this paper, we have presented a roadmap for interfacing the proposed device with smartphone based read-out systems, for smart healthcare. Such a system would eliminate the need of using bulky instrumentation for data acquisition from electrochemical sensors, and facilitate point-of-care diagnosis.
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